New Treatment Strategies in Aggressive B-Cell Lymphomas: Advances, Application, and a Glimpse of the Future

Learn how the experts are individualizing treatment selection and managing adverse events associated with established and emerging therapies for patients with MCL and DLBCL in this program centered around a dynamic live symposium at ASCO 2022. Download slides and watch the on-demand webcast from the live symposium read an expert-authored commentary and download a clinical summary resource for the discussed agents.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Bristol Myers Squibb

Genmab US, Inc.

Incyte Corporation

Lilly